Association of non-synonymous mutations in CD1A and CD1D genes with colorectal cancer in Saudi Arabia

S. Alomar, J. Al-Tamimi, T. Almanaa, A. Al-jurayyan, L. Mansour
Published: April 30, 2020
Genet. Mol. Res. 19(2): GMR18563
DOI: https://doi.org/10.4238/gmr18563

Cite this Article:
S. Alomar, J. Al-Tamimi, T. Almanaa, A. Al-jurayyan, L. Mansour (2020). Association of non-synonymous mutations in CD1A and CD1D genes with colorectal cancer in Saudi Arabia. Genet. Mol. Res. 19(2): GMR18563. https://doi.org/10.4238/gmr18563

About the Authors
S. Alomar, J. Al-Tamimi, T. Almanaa, A. Al-jurayyan, L. Mansour

Corresponding Author
L. Mansour
Email: lamjed.mansour@gmail.com

ABSTRACT

Cluster of differentiation 1 (CD1) is antigen-presenting molecule involved in the presentation of lipid and glycolipid antigens to specific T cells and natural killer T cells. They exhibit a low rate of polymorphism compared to classical major histocompatibility complex presenting molecules. In this case control study, we examined a possible association of genetic polymorphism in CD1A and CD1D genes with colorectal cancer (CRC) in a Saudi population consisting of 120 patients with CRC and 118 matched controls. They were genotyped for the CD1A T/C 622 and CD1D A/T 354 polymorphisms using PCR-SSP. An apparent protective effect of the C allele, heterozygous TC and additive TC + CC genotypes against CRC was observed. These associations were found only in individuals >57 years.   No association was observed between the CD1D A/T 354 polymorphism and CRC.

Keywords: CD1 antigen presenting molecules, Colorectal cancer, Genetic polymorphism, Saudi Arabia.

Back To Top